ICOS Antibody Stable in Head and Neck Most cancers

ICOS Antibody Stable in Head and Neck Most cancers

Current accepted of delight in evolved head and neck squamous cell carcinoma includes the anti-PD-1 checkpoint inhibitor pembrolizumab (Keytruda) with or without chemotherapy (platinum/5-fluorouracil [5-FU]). The INDUCE-1 trial — led by Erminia Massarelli, MD, PhD, a thoracic oncology specialist at…

When a Most cancers Affected person Tests Sure for Covid-19

When a Most cancers Affected person Tests Sure for Covid-19

Clementa Moreno/Getty Pictures We’ve made our coronavirus coverage free for all readers. To web all of HBR’s vow material introduced to your inbox, label up for the Day-to-day Alert publication. The Covid-19 pandemic has placed exceptional requires on health care…